Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS

KOSPI

5,383.80

-300.00 (-5.28%)

KOSDAQ

678.41

-36.54 (-5.11%)

KOSPI 200

837.78

-51.47 (-5.79%)

USD/KRW

1,342.10

Home›Reports›128940

128940KOSPI·Oct 28, 2026

Concerns appear to be peaking

Hanmi Pharm. Co., Ltd.Mirae Asset SecuritiesSeung-min Kim

Read original PDF ↗

HP

Source: Mirae Asset Securities
Type: Company Analysis
Language: English
Rating: Buy
Target price: -
Collected: Nov 08, 2026

The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 128940

Third deal this year; focus now turns to Merck��s data readoutMirae Asset Securities · Nov 02, 2026 Roche��s answer to Eli Lilly and Novo NordiskMirae Asset Securities · Aug 26, 2026 Focus on Beijing Hanmi��s recovery and pipeline progressMirae Asset Securities · Jul 29, 2026 Eli Lilly deal adds to pipeline valueMirae Asset Securities · Jun 04, 2026 Sailing With LillyKB Securities · Jun 02, 2026 Initiating Coverage: Core Business Recovery; Obesity, R&D NextKB Securities · May 27, 2026

All reports for 128940 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.

Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.

KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources

Terms Refunds Disclaimer Privacy